US Patent Litigations are now available. Check here

Explore Syndax Pharmaceuticals's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Patent NumberGrant DateTitleTotal Oppositions
EP3270966May 1, 2024Combination Of Hdac Inhibitor And Anti-Pd-1 Antibody For Treatment Of Cancer2
EP2751267Jan 24, 2018Methods For The Treatment Of Breast Cancer2